Shuttle Pharmaceuticals Holdings (SHPH) Change in Account Payables (2021 - 2024)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Change in Account Payables of -$446.0 for Q1 2024, up 96.43% year-over-year from -$227.05 in Q2 2023, and down 200.0% quarter-over-quarter from $446.0 in Q4 2023.
Shuttle Pharmaceuticals Holdings (SHPH) Change in Account Payables (2021 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Change in Account Payables history runs 4 years deep, the most recent figure standing at -$446.0 for Q1 2024.
- In Q1 2024, Change in Account Payables rose 96.43% year-over-year to -$446.0; the TTM figure through Dec 2024 stood at -$446.0 (up 96.3% YoY), while the FY2024 annual figure was -$446.0, up 96.3% from the prior year.
- Change in Account Payables for Q1 2024 stood at -$446.0, down from $446.0 in the prior quarter.
- The five-year high for Change in Account Payables was $404973.0 in Q4 2022, with the low at -$12500.0 in Q1 2023.
- The 4-year median for Change in Account Payables is $446.0 (2023), against an average of $140034.8.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables tumbled 99.89% in 2023, then jumped 96.43% in 2024.
- Shuttle Pharmaceuticals Holdings' Change in Account Payables stood at $307701.0 in 2021, then jumped by 31.61% to $404973.0 in 2022, then sank by 99.89% to $446.0 in 2023, then slumped by 200.0% to -$446.0 in 2024.
- Business Quant data shows SHPH's Change in Account Payables at -$446.0 in Q1 2024, $446.0 in Q4 2023, and -$12500.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -446.00 |
| Mar 31, 2024 | -446.00 |
| Dec 31, 2023 | 446.00 |
| Dec 31, 2023 | 446.00 |
| Mar 31, 2023 | -12,500.00 |
| Mar 31, 2023 | -12,500.00 |
| Dec 31, 2022 | 404,973.00 |
| Dec 31, 2022 | 404,973.00 |
| Dec 31, 2021 | 307,701.00 |
| Dec 31, 2021 | 307,701.00 |